Effect of hyperthermia combined with intracavitary infusion chemotherapy on abdominal cancer with malignant pleural effusion and ascites
HUANG Hansheng YANG Xiaomei FU Junmin CHEN Chaoting WEN Jianmei MO Qia
Medical Oncology Department, the Second Affiliated Hospital of Guangxi University of Science and Technology, Guangxi Zhuang Autonomous Region, Liuzhou 545006, China
Abstract：Objective To investigate the clinical efficacy of hyperthermia combined with intracavitary infusion chemotherapy on abdominal cancer with malignant pleural effusion and ascites and its influence on tumor markers in serum and pleural effusion and ascites. Methods From January 2017 to May 2018, 80 cases of patients with abdominal cancer and malignant pleural effusion admitted to the Second Affiliated Hospital of Guangxi University of Science and Technology were selected. The patients were divided into control group (n = 40) and study group (n = 40) according to the random number table method. Patients in the control group were treated with intravitreal chemotherapy, and patients in the study group were treated with hyperthermia combined with intravitreal chemotherapy. Patients in the two groups were treated for 4 weeks continuously, and the short-term effects of the two groups were evaluated and compared. Serum (CEA), saccharide antigen 19-9 (CA19-9), saccharide antigen 12-5 (CA12-5) and cytokeratin 19 fragment (CYFRA21-1) of the two groups were measured before and after treatment, respectively, and toxic and adverse reactions of the two groups were observed. Results The total effective rate of the study group was higher than that of the control group (P ＜ 0.01). Compared with before treatment, CEA, CA19-9, CA12-5 and CYFRA21-1 levels in serum and hydrothorax of the two groups were significantly reduced after treatment (P ＜ 0.05), and the levels in the study group were lower than those in the control group (P ＜ 0.05). No serious adverse reactions occurred during the treatment in both groups. Conclusion The short-term effect of hyperthermia combined with intravitary perfusion chemotherapy in the treatment of abdominal cancer with malignant pleural effusion is significant, which can significantly reduce the level of relevant tumor markers in serum and pleural effusion, and has a good safety.
黄汉生 杨小梅 傅军民 陈超庭 文建梅 莫恰. 热疗联合腔内灌注化疗治疗腹部癌症并发恶性胸腹水的效果[J]. 中国医药导报, 2019, 16(16): 91-94.
HUANG Hansheng YANG Xiaomei FU Junmin CHEN Chaoting WEN Jianmei MO Qia. Effect of hyperthermia combined with intracavitary infusion chemotherapy on abdominal cancer with malignant pleural effusion and ascites. 中国医药导报, 2019, 16(16): 91-94.
2019, Vol. 16 
京公网安备 11010502046598号